An update on Peginterferon beta-1a Management in Multiple Sclerosis: results from an interdisciplinary Board of German and Austrian Neurologists and dermatologists

被引：0
|
作者：
Annette Kolb-Mäurer
Cord Sunderkötter
Borries Kukowski
Sven G. Meuth
机构：
[1] Universitätsklinikum Würzburg,Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie
[2] 06120 Halle (Saale) und Abteilung für translationale Dermatoinfektiologie,Universitätsklinik und Poliklinik für Dermatologie und Venerologie, Ernst
[3] Nervenärztliche Gemeinschaftspraxis,Grube
[4] Universitätsklinikum Münster,Str. 40
[5] Albert-Schweitzer-Campus 1,Klinik für Neurologie
来源：
BMC Neurology | / 19卷
关键词：
Multiple sclerosis; Peginterferon bet-1a; Interferon beta; Flu-like symptoms; Injection site reactions; Management;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] An update on Peginterferon beta-1a Management in Multiple Sclerosis: results from an interdisciplinary Board of German and Austrian Neurologists and dermatologists
    Kolb-Maeurer, Annette
    Sunderkoetter, Cord
    Kukowski, Borries
    Meuth, Sven G.
    BMC NEUROLOGY, 2019, 19 (1)
  • [2] Peginterferon Beta-1a (Plegridy) for Multiple Sclerosis
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2015, 57 (1468): : 1 - 3
  • [3] Peginterferon beta-1a in multiple sclerosis: 2-year results from ADVANCE
    Kieseier, Bernd C.
    Arnold, Douglas L.
    Balcer, Laura J.
    Boyko, Alexey A.
    Pelletier, Jean
    Liu, Shifang
    Zhu, Ying
    Seddighzadeh, Ali
    Hung, Serena
    Deykin, Aaron
    Sheikh, Sarah I.
    Calabresi, Peter A.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 (08) : 1025 - 1035
  • [4] Peginterferon beta-1a reduces the psychological impact of multiple sclerosis relapses: results from the ADVANCE study
    Kinter, E.
    Guo, S.
    Altincatal, A.
    Proskorovsky, I.
    Phillips, G.
    Sperling, B.
    JOURNAL OF NEUROLOGY, 2014, 261 : S441 - S441
  • [5] Multiple Sclerosis New Study Data to Peginterferon beta-1a
    不详
    AKTUELLE NEUROLOGIE, 2015, 42 (06) : 376 - 376
  • [6] Peginterferon beta-1a reduces the psychological impact of multiple sclerosis relapses: results from the ADVANCE study
    Kinter, E.
    Guo, S.
    Altincatal, A.
    Proskorovsky, I.
    Phillips, G.
    Sperling, B.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 681 - 681
  • [7] Peginterferon beta-1a for the treatment of relapsing multiple sclerosis: A case series
    Hendin, Barry A.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2018, 26 : 33 - 36
  • [8] Long-term outcomes of peginterferon beta-1a in multiple sclerosis: results from the ADVANCE extension study, ATTAIN
    Newsome, Scott D.
    Scott, Thomas F.
    Arnold, Douglas L.
    Nelles, Gereon
    Hung, Serena
    Cui, Yue
    Shang, Shulian
    Naylor, Maria L.
    Kremenchutzky, Marcelo
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2018, 11
  • [9] PEGylated interferon beta-1a in the treatment of multiple sclerosis - an update
    Reuss, Reinhard
    BIOLOGICS-TARGETS & THERAPY, 2013, 7 : 131 - 138
  • [10] Peginterferon beta-1a concentrations in breast milk of lactating multiple sclerosis patients
    Houtchens, Maria
    Mahlanza, Tatenda
    Ciplea, Andrea, I
    Manieri, Maria Claudia
    Ramia, Nancy F.
    Zhao, Yuan
    England, Sarah
    Avila, Robin
    Altincatal, Arman
    Vignos, Megan
    Hellwig, Kerstin
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 60
12345